{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T00:31:16Z","timestamp":1709512276215},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3,2]]},"DOI":"10.7759\/cureus.55414","type":"journal-article","created":{"date-parts":[[2024,3,3]],"date-time":"2024-03-03T04:46:00Z","timestamp":1709441160000},"source":"Crossref","is-referenced-by-count":0,"title":["A Unique Case of Late Presentation Giant Lower Extremity Malignant Melanoma"],"prefix":"10.7759","author":[{"given":"Omar","family":"Al Zarkali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"Marker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lakhvir","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"VanDerWall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/SMJ.0b013e3181f3d756","article-title":"Giant melanoma: novel problem, same approach","volume":"103","author":"Grisham AD","year":"2010","unstructured":"Grisham AD. Giant melanoma: novel problem, same approach. South Med J. 2010, 103:1161-2. 10.1097\/SMJ.0b013e3181f3d756","journal-title":"South Med J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.152.5.1009","article-title":"Subcutaneous metastases from malignant melanoma: prevalence and findings on CT","volume":"152","author":"Patten RM","year":"1989","unstructured":"Patten RM, Shuman WP, Teefey S. Subcutaneous metastases from malignant melanoma: prevalence and findings on CT. AJR Am J Roentgenol. 1989, 152:1009-12. 10.2214\/ajr.152.5.1009","journal-title":"AJR Am J Roentgenol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2015-212253","article-title":"Patient with giant upper limb melanoma presenting to a UK plastic surgery unit: differentials and experience of management","volume":"2016","author":"Honeyman CS","year":"2016","unstructured":"Honeyman CS, Wilson P. Patient with giant upper limb melanoma presenting to a UK plastic surgery unit: differentials and experience of management. BMJ Case Rep. 2016, 2016:10.1136\/bcr-2015-212253","journal-title":"BMJ Case Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.16996","article-title":"Unusual presentation of giant upper limb malignant melanoma","volume":"13","author":"Khim OG","year":"2021","unstructured":"Khim OG, Leong JF, Sani MH, Mohamed Haflah NH. Unusual presentation of giant upper limb malignant melanoma. Cureus. 2021, 13:e16996. 10.7759\/cureus.16996","journal-title":"Cureus"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.27701","article-title":"A case report of metastatic giant sarcomatoid melanoma with BRAF V600E mutation: a complete response to targeted therapy","volume":"11","author":"Torresetti M","year":"2020","unstructured":"Torresetti M, Brancorsini D, Morgese F, Cognigni V, Scalise A, Berardi R, Di Benedetto G. A case report of metastatic giant sarcomatoid melanoma with BRAF V600E mutation: a complete response to targeted therapy. Oncotarget. 2020, 11:3256-62. 10.18632\/oncotarget.27701","journal-title":"Oncotarget"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.4081\/rt.2011.e28","article-title":"Salvage surgery for a giant melanoma on the back","volume":"3","author":"Kruijff S","year":"2011","unstructured":"Kruijff S, Vink R, Klaase J. Salvage surgery for a giant melanoma on the back. Rare Tumors. 2011, 3:e28. 10.4081\/rt.2011.e28","journal-title":"Rare Tumors"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/bcr.07.2009.2073","article-title":"Giant cutaneous melanomas: evidence for primary tumour induced dormancy in metastatic sites?","volume":"2009","author":"Tseng WW","year":"2009","unstructured":"Tseng WW, Doyle JA, Maguiness S, Horvai AE, Kashani-Sabet M, Leong SP. Giant cutaneous melanomas: evidence for primary tumour induced dormancy in metastatic sites?. BMJ Case Rep. 2009, 2009:10.1136\/bcr.07.2009.2073","journal-title":"BMJ Case Rep"},{"key":"ref8","doi-asserted-by":"crossref","DOI":"10.5348\/Z09-2015-1-CR-1","article-title":"Giant malignant melanoma of the anterior chest wall with widespread metastasis","volume":"1","author":"Duma N","year":"2015","unstructured":"Duma N, Khan AM, Kasimis B, Chang V. Giant malignant melanoma of the anterior chest wall with widespread metastasis. J Case Rep Images Med. 2015, 1:1-4.","journal-title":"J Case Rep Images Med"},{"key":"ref9","article-title":"Giant malignant melanoma: a case report","volume":"54","author":"Kiyak MV","year":"2012","unstructured":"Kiyak MV, Yesilada AK, Sevim KZ, Usta U. Giant malignant melanoma: a case report. Acta Chir Plast. 2012, 54:59-61.","journal-title":"Acta Chir Plast"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.9790\/0853-1505017375","article-title":"Giant malignant melanoma of scalp in a 15 year old boy with widespread metastases at presentation","volume":"15","author":"Sarkar S","year":"2016","unstructured":"Sarkar S, Maiti M, Barman NM, et al.. Giant malignant melanoma of scalp in a 15 year old boy with widespread metastases at presentation. IOSR J Dent Med Sci. 2016, 15:73-5. 10.9790\/0853-1505017375","journal-title":"IOSR J Dent Med Sci"},{"key":"ref11","article-title":"Giant malignant melanomas and their clinical implications: review of literature and case report","volume":"1","author":"Gishen K","year":"2016","unstructured":"Gishen K, Maria DJP, Khanlari M, et al.. Giant malignant melanomas and their clinical implications: review of literature and case report. Clin Surg. 2016, 1:1096.","journal-title":"Clin Surg"},{"key":"ref12","article-title":"Giant scalp melanoma: a case report and review of the literature","volume":"12","author":"Ching JA","year":"2012","unstructured":"Ching JA, Gould L. Giant scalp melanoma: a case report and review of the literature. Eplasty. 2012, 12:e51.","journal-title":"Eplasty"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.5070\/D308m9k707","article-title":"Massive nodular melanoma: a case report","volume":"13","author":"Harting M","year":"2007","unstructured":"Harting M, Tarrant W, Kovitz CA, Rosen T, Harting MT, Souchon E. Massive nodular melanoma: a case report. Dermatol Online J. 2007, 13:7. 10.5070\/D308m9k707","journal-title":"Dermatol Online J"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.01763","article-title":"Combination dabrafenib and trametinib versus combination nivolumab and ipilimumab for patients with advanced BRAF-mutant melanoma: the DREAMseq Trial-ECOG-ACRIN EA6134","volume":"41","author":"Atkins MB","year":"2023","unstructured":"Atkins MB, Lee SJ, Chmielowski B, et al.. Combination dabrafenib and trametinib versus combination nivolumab and ipilimumab for patients with advanced BRAF-mutant melanoma: the DREAMseq Trial-ECOG-ACRIN EA6134. J Clin Oncol. 2023, 41:186-97. 10.1200\/JCO.22.01763","journal-title":"J Clin Oncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2020.2288","article-title":"Association of BRAF V600E\/K mutation status and prior BRAF\/MEK inhibition with pembrolizumab outcomes in advanced melanoma: pooled analysis of 3 clinical trials","volume":"6","author":"Puzanov I","year":"2020","unstructured":"Puzanov I, Ribas A, Robert C, et al.. Association of BRAF V600E\/K mutation status and prior BRAF\/MEK inhibition with pembrolizumab outcomes in advanced melanoma: pooled analysis of 3 clinical trials. JAMA Oncol. 2020, 6:1256-64. 10.1001\/jamaoncol.2020.2288","journal-title":"JAMA Oncol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30388-2","article-title":"Pembrolizumab versus ipilimumab in advanced melanoma (KEYNOTE-006): post-hoc 5-year results from an open-label, multicentre, randomised, controlled, phase 3 study","volume":"20","author":"Robert C","year":"2019","unstructured":"Robert C, Ribas A, Schachter J, et al.. Pembrolizumab versus ipilimumab in advanced melanoma (KEYNOTE-006): post-hoc 5-year results from an open-label, multicentre, randomised, controlled, phase 3 study. Lancet Oncol. 2019, 20:1239-51. 10.1016\/S1470-2045(19)30388-2","journal-title":"Lancet Oncol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.23.4799","article-title":"Final version of 2009 AJCC melanoma staging and classification","volume":"27","author":"Balch CM","year":"2009","unstructured":"Balch CM, Gershenwald JE, Soong SJ, et al.. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009, 27:6199-206. 10.1200\/JCO.2009.23.4799","journal-title":"J Clin Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/211541-a-unique-case-of-late-presentation-giant-lower-extremity-malignant-melanoma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,3]],"date-time":"2024-03-03T04:46:05Z","timestamp":1709441165000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/211541-a-unique-case-of-late-presentation-giant-lower-extremity-malignant-melanoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,2]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.55414","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3,2]]}}}